File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas

TitleMolecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas
Authors
KeywordsChromosome 3p
Hemangioblastoma
Loss of heterozygosity
Single-strand conformation polymorphism
von Hippel-Lindau gene
Issue Date1997
Citation
American Journal of Clinical Pathology, 1997, v. 107, n. 4, p. 459-466 How to Cite?
AbstractCerebellar hemangioblastoma is one of the most frequent manifestations of the autosomal dominantly inherited von Hippel-Lindau (VHL) disease but also may manifest as a sporadic tumor. The purpose of this study was to define the alterations of the VHL gene in hemangioblastomas. We analyzed nine specimens from eight cerebellar hemangioblastomas (three familial and five sporadic) and six blood samples from family members of two unrelated pedigrees for mutations of the VHL gene using single-strand conformation polymorphism analysis and direct sequencing. We identified germline mutations in all VHL-associated tumors and somatic mutations in two (40%) of five sporadic hemangioblastomas. We also observed germline mutations in the peripheral blood DNA from members of two unrelated ramifies; one is currently without VHL manifestations, and the other is affected. In addition, loss of heterozygosity of allelic markers on chromosome 3p were examined by four polymorphic microsatellite markers, and aberrant methylation of the VHL gene was investigated with a methylation-sensitive enzyme, Sma I. Allelic losses on chromosome 3p were observed from two patients with VHL disease in one family and in one of two sporadic hemangioblastomas. No hypermethylation of the VHL gene was detected in any of the tumors that we examined. Our findings suggest that the VHL tumor suppressor gene is the target for inactivation in this tumor and is involved in the pathogenesis of familial and sporadic hemangioblastomas.
Persistent Identifierhttp://hdl.handle.net/10722/325007
ISSN
2023 Impact Factor: 2.3
2023 SCImago Journal Rankings: 0.775

 

DC FieldValueLanguage
dc.contributor.authorTse, Jenny Y.M.-
dc.contributor.authorWONG, JOSEPH H.C.-
dc.contributor.authorLo, KWOK WA-
dc.contributor.authorPoon, Wai Sang-
dc.contributor.authorHUANG, DOLLY P.-
dc.contributor.authorNG, HO KEUNG-
dc.date.accessioned2023-02-27T07:28:57Z-
dc.date.available2023-02-27T07:28:57Z-
dc.date.issued1997-
dc.identifier.citationAmerican Journal of Clinical Pathology, 1997, v. 107, n. 4, p. 459-466-
dc.identifier.issn0002-9173-
dc.identifier.urihttp://hdl.handle.net/10722/325007-
dc.description.abstractCerebellar hemangioblastoma is one of the most frequent manifestations of the autosomal dominantly inherited von Hippel-Lindau (VHL) disease but also may manifest as a sporadic tumor. The purpose of this study was to define the alterations of the VHL gene in hemangioblastomas. We analyzed nine specimens from eight cerebellar hemangioblastomas (three familial and five sporadic) and six blood samples from family members of two unrelated pedigrees for mutations of the VHL gene using single-strand conformation polymorphism analysis and direct sequencing. We identified germline mutations in all VHL-associated tumors and somatic mutations in two (40%) of five sporadic hemangioblastomas. We also observed germline mutations in the peripheral blood DNA from members of two unrelated ramifies; one is currently without VHL manifestations, and the other is affected. In addition, loss of heterozygosity of allelic markers on chromosome 3p were examined by four polymorphic microsatellite markers, and aberrant methylation of the VHL gene was investigated with a methylation-sensitive enzyme, Sma I. Allelic losses on chromosome 3p were observed from two patients with VHL disease in one family and in one of two sporadic hemangioblastomas. No hypermethylation of the VHL gene was detected in any of the tumors that we examined. Our findings suggest that the VHL tumor suppressor gene is the target for inactivation in this tumor and is involved in the pathogenesis of familial and sporadic hemangioblastomas.-
dc.languageeng-
dc.relation.ispartofAmerican Journal of Clinical Pathology-
dc.subjectChromosome 3p-
dc.subjectHemangioblastoma-
dc.subjectLoss of heterozygosity-
dc.subjectSingle-strand conformation polymorphism-
dc.subjectvon Hippel-Lindau gene-
dc.titleMolecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1093/ajcp/107.4.459-
dc.identifier.pmid9124215-
dc.identifier.scopuseid_2-s2.0-0031003674-
dc.identifier.volume107-
dc.identifier.issue4-
dc.identifier.spage459-
dc.identifier.epage466-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats